InvestorsHub Logo
Followers 8
Posts 3893
Boards Moderated 1
Alias Born 06/28/2005

Re: None

Friday, 05/26/2006 4:35:44 PM

Friday, May 26, 2006 4:35:44 PM

Post# of 45771
Re the Argonne Labs technology, the ASD patent makes claims to the detection of pharmaceutical products using light in the infrared, visible and ultraviolet regions of the spectrum. The Argonne technology uses light in the terahertz range (one billion hertz) which lies between microwaves and infrared. ASD has no claims in the terahertz range.

That alone is a good reason why I don't believe Argonne is infringing on ASD patent claims and their tech development will have no effect on the suit against CDEx.

Apples and organes.

Valimed operates in the UV range claimed by ASD and is being marketed specifically to do the same things as disclosed in the ASD patent.

Apples and apples?

And BTW, a link to another company developing this same terahertz technology was posted some time ago and mostly ignored by readers... just like my post about the ASD patent was ignored 15 months ago.






Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.